• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

Medical News Interviews

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Front Line Therapy in Non-Small Cell Lung Cancer

0
  • by alexperjescuadmin
  • in Oncology
  • — 17 Mar, 2008
Front Line Therapy in Non-Small Cell Lung Cancer
AudioMedica News
Front Line Therapy in Non-Small Cell Lung Cancer
Front Line Therapy in Non-Small Cell Lung Cancer
00:00 /
RSS Feed
Share
Link
Embed
Nick Thatcher
Nick Thatcher

NICK THATCHER, Christie Hospital, Manchester
There is a proven benefit in survival if you give your patients cis-platinum based chemotherapy after resection for non-small cell lung cancer. Nick Thatcher emphasized this fact at the beginning of his talk in Turin about front line therapy for non-small cell lung cancer. He went on to discuss optimizing therapy with respect to histology, performance status and the addition of targeted agents. Peter Goodwin interviewed him about his recommendations.



LISTEN

[audio:https://www.audiomedica.com/podcasting/oncology/080316_nick_thatcher.mp3]

Share

Tags: agentcancerchemotherapyinterviewlungpatientsurvivaltherapies

You may also like...

  • Breast Cancer: Further Support for Trastuzumab from Combined Analysis Breast Cancer: Further Support for Trastuzumab from Combined Analysis 30 Oct, 2005
  • Ribociclib Aids First-Line Endocrine Therapy in Premenopausal Advanced Breast Cancer Ribociclib Aids First-Line Endocrine Therapy in Premenopausal Advanced Breast Cancer 18 Apr, 2018
  • Daniel W. Lee Chimeric antigen receptor T-cell therapy rescues kids with relapsing acute lymphoblastic leukaemia 9 Apr, 2013
  • Oncology Times Broadcast News with the Audio Journal of Oncology Oncology Times Broadcast News with the Audio Journal of Oncology 7 Jan, 2009

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Previous story New Targets Bring Promise For Lung Cancer Therapy
  • Next story Debate: Adjuvant Chemotherapy Should Be Standard in Stage I Non-Small Cell Lung Cancer
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Ibrutinib: New Frontline Standard for Chronic…
    • Microbiome Diversity Key To Survival After…
    • Pembrolizumab: No Survival Gains Second Line In…
    • New Front Line Standard for Older Patients with…
    • BRCA1/2 Ovarian Cancer—Three Years Disease Free…
  • Home
  • Oncology
  • Front Line Therapy in Non-Small Cell Lung Cancer

© Copyright 2021 AudioMedica.com. Typegrid Theme by WPBandit.